Prominent health care organizations urge the Trump administration to restore important data sets on the Centers for Disease ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

The executive order could come as soon as next week, if the Trump administration goes ahead with plans, according to people ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

A new watchdog report highlights the ongoing issues concerning the oversight of foodborne illness in the United States and stresses the need for a national food ...

Our fundamental challenge is not simply to create the data. Rather, it is to collect and analyze it systematically. Doing so ...

Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...

CHICAGO — A man who laundered money for a Chicago-based drug trafficking organization was handed an eight-year federal prison sentence this week after spending more than a decade on the run.

The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

In a statement Tuesday, the organization said it regretted the US decision, noting that it had, “over the past 7 years implemented the largest set of reforms in its history, to transform our ...